Propanal → 2-methyl-4-[4-[(E)-pent-1-enyl]sulfonylpiperazin-1-yl]quinoline
反応式
C(OP([CH2:9][S:10]([N:13]1[CH2:18][CH2:17][N:16]([C:19]2[C:28]3[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=3)[N:22]=[C:21]([CH3:29])[CH:20]=2)[CH2:15][CH2:14]1)(=[O:12])=[O:11])(OCC)=O)C.[Br-].[Li+].C(=O)CC.[CH2:36]1[CH2:46]CN2C(=NCCC2)[CH2:38][CH2:37]1>C1COCC1.ClCCl>[CH3:29][C:21]1[CH:20]=[C:19]([N:16]2[CH2:15][CH2:14][N:13]([S:10](/[CH:9]=[CH:46]/[CH2:36][CH2:37][CH3:38])(=[O:12])=[O:11])[CH2:18][CH2:17]2)[C:28]2[C:23](=[CH:24][CH:25]=[CH:26][CH:27]=2)[N:22]=1参加物
7
反応物 4
生成物 1
試薬・触媒・溶媒 2
反応条件
- 温度
- -10 °C
実験手順
4-[4-(Diethoxyphosphorylmethylsulfonyl)piperazin-1-yl]-2-methyl-quinoline (47 mg, 0.106 mmol) was dissolved in anhydrous THF (1 ml), lithium bromide (11.1 mg, 0.128 mmol) and propionaldehyde (9.2 μl, 0.128 mmol) were added with stirring and the mixture was cooled to −10° C. DBU (15.2 μl, 0.102 mmol) was added, and the temperature was raised to room temperature. Stirring was continued for 30 minutes, the reaction mixture was diluted with dichloromethane, washed with 5% sodium bicarbonate solution (2×), water and evaporated to dryness. The residue was purified with preparative HPLC (gradient of water containing 0.1% ammonia and acetonitrile). 5 mg of a solid were obtained (0.014 mmol, 14%).
後処理
- temperaturethe temperature was raised to room temperature
- stirringStirring
- washwashed with 5% sodium bicarbonate solution (2×), water
- customevaporated to dryness
- customThe residue was purified with preparative HPLC (gradient of water containing 0.1% ammonia and acetonitrile)
出典と根拠
- ORDレコード
- ord-fcc0a5ed81fd48d980d45a3625a6b33a
- 出典データセット
- uspto-grants-2014_11
- 特許番号
- US08883791B2
反応ノート
読み込み中…